PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2006.38.3.1212006383121A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric CancerSe Hoon Park, Soo Yeon Jeon, Kwang Il Ko, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Ki Lee, Min Chunghttp://www.e-crt.org/upload/pdf/crt-38-121.pdf, http://www.e-crt.org/upload/pdf/crt-38-121.pdf
Annals of Oncology10.1093/annonc/mdm5022008194729-733Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancerS.H. Park, E. Nam, J. Park, E.K. Cho, D.B. Shin, J.H. Lee, W.K. Lee, M. Chung, S.I. Leehttps://api.elsevier.com/content/article/PII:S0923753419414373?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419414373?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/19/4/729/579012/mdm502.pdf
Gastric Cancer10.1007/s10120005002219992157-63Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a Phase II study with 5-fluorouracil, leucovorin, and cisplatinAtsushi Nashimoto, Hiroshi Yabusaki, Otsuo Tanaka, Juei Sasaki, Nobuhiro Akiyamahttp://link.springer.com/content/pdf/10.1007/s101200050022.pdf, http://link.springer.com/article/10.1007/s101200050022/fulltext.html, http://link.springer.com/content/pdf/10.1007/s101200050022
Gastric Cancer10.1007/s10120-018-0825-y20182161050-1057Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecanChihiro Kondoh, Shigenori Kadowaki, Azusa Komori, Yukiya Narita, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Kei Murohttp://link.springer.com/article/10.1007/s10120-018-0825-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-018-0825-y.pdf, http://link.springer.com/content/pdf/10.1007/s10120-018-0825-y.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(09)71299-6200972383-3846578 A randomized phase II study of irinotecan monotherapy versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancerY. Park, S. Sym, J. Park, E. Cho, D. Shin, J. Leehttps://api.elsevier.com/content/article/PII:S1359634909712996?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634909712996?httpAccept=text/plain
Chonnam Medical Journal10.4068/cmj.2009.45.2.79200945279Phase II Study of Irinotecan, High-dose 5-fluorouracil, and Leucovorin Combination Chemotherapy in Taxane and Cisplatin-based Chemotherapy-refractory Metastatic Gastric CancerJu-Young Yoon, Sung-Ji Lee, Dae-Ho Cho, Sung-Yoon Rew, Dae-Eun Kim, Jun-Eul Hwang, Woo-Kyun Bae, Hyun-Jeong Shim, Sang-Hee Cho, Ik-Joo Chunghttps://synapse.koreamed.org/DOIx.php?id=10.4068/cmj.2009.45.2.79, https://synapse.koreamed.org/pdf/10.4068/cmj.2009.45.2.79, https://cmj.ac.kr/DOIx.php?id=10.4068/cmj.2009.45.2.79
Gastric Cancer10.1007/pl00011737200143144-149Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: efficacy and feasibility in clinical practiceMotoki Yoshida, Narikazu Boku, Atsushi Ohtsu, Manabu Muto, Fumio Nagashima, Shigeaki Yoshidahttp://link.springer.com/content/pdf/10.1007/PL00011737.pdf, http://link.springer.com/article/10.1007/PL00011737/fulltext.html, http://link.springer.com/content/pdf/10.1007/PL00011737
Medical Oncology10.1007/s12032-009-9340-720092741089-1095Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communicationYanlei Ma, Huanlong Qin, Qi Zheng, Yu Wang, Zhiguo Wang, Zhe Yanghttp://link.springer.com/content/pdf/10.1007/s12032-009-9340-7.pdf, http://link.springer.com/article/10.1007/s12032-009-9340-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12032-009-9340-7
Chemotherapy10.1159/0000947692006525264-270Irinotecan Combined with Infusional 5-Fluorouracil and High-Dose Leucovorin for the Treatment of Advanced Gastric Carcinoma as the First-Line ChemotherapyUgur Yilmaz, Ilhan Oztop, Ahmet Alacacioglu, Arzu Yaren, Oktay Tarhan, Isil Somalihttps://www.karger.com/Article/Pdf/94769, https://www.karger.com/Article/Pdf/94769
Cancer Chemotherapy and Pharmacology10.1007/bf00686115199434172-74Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot studyStefano Cascinu, Anna Fedeli, Giuseppina Catalanohttp://link.springer.com/content/pdf/10.1007/BF00686115.pdf, http://link.springer.com/article/10.1007/BF00686115/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF00686115